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Coupling immunity and
programmed cell suicide in prokaryotes:
Life-or-death choices
Eugene V. Koonin1) and Feng Zhang2)3)4)5)
Host-pathogen arms race is a universal, central aspect
of the evolution of life. Most organisms evolved several
distinct yet interacting strategies of anti-pathogen
defense including resistance to parasite invasion, innate
and adaptive immunity, and programmed cell death
(PCD). The PCD is the means of last resort, a suicidal
response to infection that is activated when resistance
and immunity fail. An infected cell faces a decision
between active defense and altruistic suicide or dor-
mancy induction, depending on whether immunity is
‘‘deemed’’ capable of preventing parasite reproduction
and consequent infection of other cells. In bacteria and
archaea, immunity genes typically colocalize with PCD
modules, such as toxins-antitoxins, suggestive of
immunity-PCD coupling, likely mediated by shared
proteins that sense damage and ‘‘predict’’ the outcome
of infections. In type VI CRISPR-Cas systems, the same
enzyme that inactivates the target RNA might execute
cell suicide, in a case of ultimate integration of immunity
and PCD.
Keywords:.genotoxic stress sensing; immunity; programmed cell
death; virus-host coevolution
Introduction
Parasites are intrinsic components of all replicator sys-
tems [1–3]. Virtually no cellular life form can eliminate
parasitic genetic elements [4–6], and most organisms host
diverse classes of such elements including viruses, trans-
posons, and plasmids [7]. Thus, the entire history of life is a
story of incessant arms races between parasites and hosts
during which both sides evolve diverse offence, defense, and
counter-defense strategies [1, 2, 8]. Nearly all cellular life
forms, with the exception of some intracellular parasitic
bacteria, combine multiple anti-parasite defense mecha-
nisms [9]. The principal defense strategies include: (i)
resistance whereby the receptor for a particular parasite,
such as a virus, mutates to a form that is no longer conducive
to the parasite entry into the host cell; (ii) innate immunity, i.e.
diverse mechanisms that actively prevent the reproduction of
different parasites; (iii) adaptive (acquired) immunity, i.e.
mechanisms that involve collection of information on a
specific parasite and utilization of that information for highly
efficient and selective abrogation of its reproduction; and (iv)
programmed cell death (PCD) (and possibly more broadly,
programmed suicide of an organism) whereby an infected cell
instigates a self-destruction program that prevents parasite
reproduction from reaching completion, and thus, protects
other cells from infection [9–11]. In bacteria, the functional
systems that cause PCD, in many cases, can instead induce
dormancy (stasis), i.e. a non-reproducing cellular state
characterized by extremely low metabolic activity [12–14].
With the full realization of the importance of dormancy and
addressing it where relevant, we hereinafter generically refer
to PCD systems and mechanisms including dormancy
induction. The PCD, in a sense, is a form of innate immunity
inasmuch as the suicidal response is triggered indiscrimi-
nately by different pathogens. Nevertheless, given the
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fundamental biological difference between immunity
responses, in which cellular organisms kill or inactivate
pathogens, and PCD which entails cells (and possibly also
multicellular organisms) killing themselves, we henceforth
treat these strategies as distinct.
The recent discovery of adaptive immunity mediated by
the CRISPR-Cas (Clustered Regularly Interspaced Palindromic
Repeats and CRISPR-associated genes) systems in archaea and
bacteria has attracted enormous attention and interest [15–18].
A big part of the furor is undoubtedly due to the utility of type
II CRISPR-Cas (Cas9) as a new generation of tools for genome
editing and regulation [19–23]. However, the CRISPR-Cas
systems are also of major, fundamental biological interest,
and notably, it is the unique mechanisms of these immune
systems that make them such facile genome engineering tools.
Arguably, the most striking aspect of the CRISPR-Cas function
is that this is the only known case of adaptive immunity with
heritable genomic memory, i.e. a mechanism of (quasi)
Lamarckian inheritance of acquired characters [24]. Although
some steps of the CRISPR-Cas response seem to involve
selection, the major Lamarckian trend is obvious because
the CRISPR-Cas systems modify a specific locus in the genome
such that a unique phenotypic change (immunity to a specific
virus or plasmid) is acquired and then transmitted across
generations (in some cases, apparently millions of them) [25].
The discovery of CRISPR-Cas has stimulated extensive
scrutiny of the principles and mechanisms of action of
prokaryotic defense systems. In the process, multiple,
intricate connections between immunity and PCD have
become apparent leading to the concept of functional
coupling between the two types of defense [26, 27]. Here we
discuss different aspects of such connections, with an
emphasis on recent discoveries showing that is some defense
systems, immunity, and PCD effectively merge.
Immune systems possess an intrinsic
suicidal potential
Evenapart fromPCD,which isdedicatedmachineryforaltruistic
self-destruction, immunitymechanisms are inherently suicidal.
Simple considerations make this obvious. Immunity is a
collection of mechanisms for abrogation of reproduction and
destruction of parasites, above all, various mobile genetic
elements including viruses. Given the fundamental unity of
genetic systems across all life, cell, or virus, immunity is
dangerous by design because it will inevitably attack the host
itself unless kept in check. In the most general sense, this is a
consequence of the laws of thermodynamics that prohibit
error-less information transmission without commensurate
energy expenditure [28, 29]. The numerous, often devastating
autoimmune diseases are an obvious case in point [30, 31].
Additionally, autoimmunity has been demonstrated for the
CRISPR-Cas systems [32–34], in accord with the conceptual
notion that it is an inalienable property of immune systems.
Thus, immunity can bemaintained only when accompanied by
efficient self/non-self discrimination mechanisms that evolve
concomitantly with immunity itself. This happens when the
benefits of protection from parasites are substantial, and/or
when the immune systems themselves possess properties of
selfish elements and become “addictive” to the host as
discussed later in this section.
The principles of self/non-self discrimination differ
substantially between innate and adaptive immunity, and
these distinctions reflect the major differences between these
two types of immunity. Innate immunity systems recognize
generic properties of the self, often modifications that
these systems themselves introduce. The numerous, highly
diverse and abundant restriction-modification (RM) systems
present perhaps the most illuminating case in point [35–38].
The most common RM modules (known as type II) consist of
two proteins one of which, a methyltransferase, is responsible
for the modification (methylation) of the self and the other
one, the nuclease, targets and destroys all unmodified DNA
which, “from the point of view” of the RM systems is
equivalent to non-self (there are many intricate variations on
this theme among the RM systems that we do not have an
opportunity to describe here).
The RM systems share key properties with typical toxin-
antitoxin (TA) modules, the dedicated PCD inducers that are
even more abundant in prokaryotes than RM [9, 39, 40]. In
both the RM and TA modules, one part of the module acts as a
poison and the other one as an antidote. The similarity
between the two classes of systems is so pronounced that
sometimes they are aggregately classified as toxins-
antitoxins [41]. Yet, both the poison and the antidote function
differently in immune systems compared to dedicated suicidal
systems (Fig. 1). In the immune systems, the poison (such as a
restriction endonuclease) directly attacks the foreign DNA,
whereas the antidote (such as the corresponding methylase)
protects the host genome. In contrast, in the dedicated PCD
systems, the poison affects essential host molecules, such as
mRNAs in the case of the TA systems, which include mRNA
interferases as toxins. The antitoxin reversibly inactivates the
toxin as long as the balance between the two components is
maintained; again, there are many variants of TA systems in
which the antitoxin functions differently, e.g. by inactivating
the toxin mRNA [41–43].
The suicidal potential of the RM systems is obvious: the
restriction endonuclease would kill the host whenever the
methylation level of the host DNA perceptibly drops. In at least
some RM systems, this potential is realized via post-segrega-
tional cell killing similar to that perpetrated by TA systems:
once a RM system is lost from a cell after division, the dilution
of the modification methylase leads to exposure of under-
methylated DNA which is cleaved by the remaining restriction
enzyme, thus, resulting in cell death [44–46]. Other RM
modules attack the self DNA under specific stress conditions,
in particular at arrested replication forks [47, 48]. Further-
more, type IV restriction systems (not RM because these lack
the modification component) become suicidal when the
bacteriophage carries its own methylase that methylates the
host DNA at new sites resulting in its recognition as non-self
by the type IV enzyme [49]. Both RM and TA systems are
addictive to the host cells because when the genes encoding
both components or the antitoxin only are lost, e.g. during cell
division, the antitoxin rapidly loses activity (diluted in the
case of RM and degraded in the case of TA), and typically,
enough toxin remains to kill the microbial cell. Taken
together, all these lines of evidence indicate that, although
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immunity appears to be the primary mode of action of the RM
systems, they are not only accidentally suicidal and addictive
via post-segregational killing, but also can be – and under
various circumstances, actually are – turned into PCD devices.
Given their addictiveness and frequent transfer on plasmids,
both RM and TA systems can be considered a special kind of
mobile genetic elements [50].
The adaptive immunity system, CRISPR-Cas, appears to be
particularly precarious, in terms of the suicidal potential.
Indeed, the CRISPR-Cas loci incorporate unique spacers that
are employed as guides to recognize and cleave target nucleic
acids [17, 18]. Obviously, self-recognition – i.e. targeting
the spacer itself – by these guides would be damaging and
potentially suicidal. The CRISPR-Cas systems have evolved
specific safeguards against such direct self-recognition,
typically in the form of a sequence motif (PAM, proto-
spacer-adjacent motif) that is required for protospacer
acquisition and subsequent recognition but is missing in
the CRISPR, thus, preventing self-targeting [51–55].
However, direct self-recognition of the CRISPR arrays is
only one form of suicidal autoimmunity to which CRISPR-Cas
systems are prone. The second one involves the obvious
possibility of acquisition of spacers from the host genome,
followed by suicidal targeting [32–34]. It remains unclear
exactly how, and strikingly, even whether CRISPR-Cas
systems avoid this form of autoimmunity. In one model
system – subtype I-E CRISPR-Cas – it has been demonstrated
that substantial (although most likely, less than perfect) self/
non-self discrimination is achieved via the recognition of
actively replicating DNA that is undergoing RecBCD-mediated
repair [56]. However, in another model, namely subtype II-A
CRISPR-Cas, there seems to be no such discriminatory
mechanism so that the CRISPR response is extremely
wasteful: the majority of the bacterial cells are killed, yet,
the benefit of protecting a minority apparently
outweighs the detrimental effects of the suicidal
behavior [57].
Colocalization of genes and
interaction of proteins of
immune and PCD machineries
in prokaryotes implies
functional coupling
Apart from and beyond the suicidal properties
of immune systems, the genomic loci encoding
such systems often also include dedicated PCD
modules, such as TA, and some proteins are
shared by the two types of defense systems
(Fig. 2). CRISPR-Cas, the most complex class of
prokaryotic defense system, again presents the
most remarkable cases in point. One of the key
proteins in the first, adaptation phase of the
CRISPR response, Cas2, is a derivative of the
toxins of the VapD family of mRNA interfer-
ases [58, 59]. The primary role of Cas2 in
CRISPR-Cas is that of a structural scaffold of the
adaptation complex in which Cas1 is the active
endonuclease component [60–62]. The interferase catalytic
site is conserved in some but not all Cas2 proteins, and it has
been shown that the catalytic residues of Cas2 are not required
for adaptation [60]. Thus, at least in certain CRISPR-Cas
systems, Cas2might play a secondary role as a RNase, possibly
a toxin [26], although catalytically active Cas2 proteins do not
appear to be toxic when overexpressed in Escherichia coli.
Indeed, non-sequence-specific nuclease activity of several
Cas2 proteins against both DNA and RNA but typically,
with a preference for RNA substrates, has been demon-
strated [63–67]. The role of the nuclease activity of Cas2 in the
CRISPR-Cas function remains obscure but evolutionary
conservation of the catalytic site implies that it is functional
in at least some microbes.
Many, if not most, CRISPR-Cas systems also contain
additional nucleases, in particular (predicted) RNases of the
HEPN (Hhigher Eukaryotes and Prokaryotes Nucleotide-
binding domain) superfamily [68, 69] (Fig. 2). The RNase
activity of two of these proteins, Csm6 and Csx1, has recently
been experimentally demonstrated. Typically, the HEPN-
containing Cas proteins additionally contain the CARF
domain that adopts the Rossmann fold and is predicted to
bind ligands, most likely nucleotides, and perform signaling
functions [69]. Notably, the Csm6 protein that consists of a
CARF and a HEPN domain is not required for the type III-B
CRISPR-Cas interference [70] suggesting a different, acces-
sory function for this protein. The HEPN superfamily consists
of extremely diverse (predicted) RNases that are primarily
involved in various defense functions. In particular, a highly
abundant class of TA modules encompasses HEPN domain-
containing proteins as the toxin moieties [68]. The HEPN
domain-containing systems remain poorly functionally
characterized but are common in many prokaryotes, and
specifically, are the most abundant TA modules in
Figure 1. Immunity and programmed cell death: distinct but coupled defense
strategies. The host DNA is protected from the action of the restriction enzyme by
methylation whereas the invading DNA is sensitive. Innate immunity, in the form of RM
systems, can inactivate the parasite DNA and block infection. However, if the innate
immunity fails (e.g. due to the activity of the parasite-encoded antidefense system) and
the parasite reproduces, the infection induces genotoxic stress which activates
proteases cleaving antitoxins. The resulting activation of toxins leads to dormancy or
PCD. M, modification enzyme; R, restriction enzyme; T, toxin; A, antitoxin; MGE,
mobile genetic element.
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Figure 2. Colocalization of genes encoding immune and PCD systems in bacterial and archaeal genomes. The core genes of CRISPR-Cas,
RM, and DND systems in predicted operons are shown by pink arrows; genes with (predicted) toxin activity are shown by different colors,
and the (predicted) toxin domains are indicated by red outline. The Csa3 protein in the Type IA system lacks the HEPN domain. HEPN,
higher eukaryotes and prokaryotes nucleotide-binding domain; Sir2, ParB and REase, DEDD, nucleases from distinct superfamilies.
A: CRISPR-Cas loci. Gene names follow the nomenclature and classification from [16]. B: Restriction-modification loci. Gene names follow
the nomenclature and classification from [94]. C: Phosphorothioation loci. Gene names follow the nomenclature from [95]. D: Prokaryotic
Argonaute genes, pAgo. Reproduced from [26] under Creative Commons License.
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archaea [39, 68]. Accordingly, it appears likely that the HEPN
domain-containing Cas proteins also possess toxin activity
that could be masked by another domain of the same protein
or by a distinct Cas protein. In some CRISPR-Cas systems, the
CARF domain is fused to predicted nucleases that are
unrelated to HEPN: in particular, Cas4 homologs which
adopt the Restriction Endonuclease fold [69]. This apparent
interchangeability of CARF-linked nucleases suggests the
intriguing possibility that they are all toxins regulated
through ligand-binding by the CARF domain.
A CRISPR-associated toxin activity has been directly
demonstrated for the Csa5 protein of the type I-A CRISPR-
Cas system of the archaeon Sulofolobus solfataricus. Infection
of S. solfataricus with the SIRV2 virus induced the expression
of Csa5 to the toxic level and resulted in cell death, hence
suggesting that the toxicity of this protein indeed represents a
PCD response to virus infection [71]. The Csa5 protein is the
a-helical small subunit of the Cascade CRISPR RNA-
processing complex of type I-A and does not appear to
possess any nuclease activity [72], so the mechanism of
toxicity remains obscure. These findings suggest that the
CRISPR-associated toxicity is a broad phenomenon that goes
beyond the known activities of toxic nucleases.
Apart from the CRISPR-Cas systems, comparative genomic
analysis has revealed preferential association of dedicated
PCD systems (TA) with innate immunity loci, such as RM
[9, 26]. Taken together, these observations have prompted the
hypothesis on functional coupling between immunity and
PCD/dormancy [26]. Two versions of such coupling were
considered. First, and most intuitively, PCD can be viewed as
the strategy of last resort whereby the defense system senses
the impending failure to stop virus reproduction in the given
cell and accordingly switches to the suicidal mode, sacrificing
the infected cell but saving other cells in the population.
Alternatively, it has been speculated that faced with intense
virus reproduction, the immune system would turn on the
dormancy induction machinery, thus, not only protecting
the surrounding cells but potentially, giving the infected
cell a chance to recover once the virus clears. The two
strategies might not be completely distinct given that there is
never a guarantee that a cell re-emerges from dormancy. The
presence, in numerous CRISPR-Cas loci, of genes encoding
proteins, in which CARF domains are fused with diverse
nucleases [69] (Fig. 2), implies the interesting possibility that
the CARF domain functions as a sensor of defeat of the
immune system in the battle with the virus, probably, in
response to an alarmone that remains to be identified.
The immunity-suicide coupling hypothesis was construed
on the basis of multiple but indirect lines of evidence.
However, the experimental paradigm for this type of coupling
is presented by an antiphage defense system that includes
HEPN domain-containing RNases. These RNases, the bacterial
RloC and PrrC proteins, are anticodon nucleases (ANCases)
that both consist of an N-terminal NTPase domain and a C-
terminal HEPN RNase domain [73, 74]. The PrrC ACNase is
normally reversibly inactivated by components of a bacterial
type I RM system but is activated by a phage RM inhibitor,
resulting in an incision in the anticodon loop of tRNALys which
abrogates the synthesis of the phage late proteins [75]. This
circuit shows the predicted coupling between immunity and
PCD: inhibition of an innate immunity system (RM) triggers
PCD through the activation of a toxin. The PrrC activity is
additionally activated by GTP hydrolysis and stabilized by
dTTP which accumulates in the phage-infected bacterial
cells [76]. Thus, PrrC is effectively a toxin that is activated
through sensing multiple signals emitted by the infected
bacterium. Bacteriophages have evolved their ow, complex
antidote, namely a pair of enzymes, polynucleotide kinase,
and RNA ligase, that together repair the tRNA molecules
cleaved by PrrC [77, 78].
Apparently, the activation of the RloC ACNase is the
bacterial response to the phage tRNA repair system. RloC also
cleaves tRNAs (in this case, tRNAGlu and tRNAGln) but instead
of simply incising the anticodon loop, this ACNase excises
the wobble nucleotide, thus, precluding the repair by the
phage kinase-ligase system [79]. Similar to PrrC, RloC is also
stabilized by dTTP but does not seem to interact with RM.
Instead, RloC contains a distinct domain that is a built-in
sensor of double-stranded DNA breaks (DSB) [80, 81]. Once
an elevated level of DSB is sensed, under genotoxic stress
caused by phage infection or other factors, the sensor
domain triggers a conformation change that turns the protein
into an active toxin. Notably, activation of RloC coincides
with activation of CRISPR so that the two systems are thought
to provide complementary defenses [80]. Thus, the antiphage
ACNases, especially PrrC, given its direct connection with
RM, clearly demonstrate the link between dormancy
induction (or at least, toxic effect), in this case through
tRNA inactivation, and immunity mechanisms, such as RM
and possibly CRISPR-Cas.
In the next section, we discuss a recent discovery that
might directly link CRISPR-Cas to dormancy induction.
Type VI CRISPR-Cas systems: Dual
immunity-suicide function
The recent discovery of new Class 2 CRISPR-Cas systems, driven
by a comprehensive search for genomic loci that encode large
proteins containing putative nuclease domains that could
function as CRISPR-Cas effectors, has revealed what arguably
is themostdirect linkbetweenmicrobial immunityandPCDsofar
discovered [82–84]. Type VI effector proteins contain two HEPN
domains that are predicted to possess RNase activity [82, 84].
Such an activity requiring both HEPN domains indeed has been
demonstrated for the subtype VI-A effector (denoted C2c2, or
provisionally, Cas13a) [83]. As expected of a RNA-targeting
CRISPR effector, Cas13a provides efficient protection against the
RNA bacteriophage MS2. In addition, Cas13a showed a distinct
capacity that, though apparently highly unusual, in retrospect,
couldperhapshave beenpredicted.Whenprimedwith a cognate
RNA, thisproteinbecomesapromiscuousRNase that cleaves any
RNA molecules present in the reaction mix with little sequence
specificity (Fig. 3). Moreover, a decrease in bacterial viability was
observed when Cas13a was coexpressed with the cognate RNA,
suggesting dormancy induction [83]. Given the apparent minor
contribution of RNA bacteriophages to the bacterial viro-
sphere [85], it appearsmost likely that the principal functionality
of subtype VI-A is defense against DNA phages that is realized
through the toxic effect that is triggered by the recognition of a
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cognate phage transcript and leads to dormancy or PCD. Clearly,
this hypothesis remains to be tested directly.
Thus, the HEPN domain, an RNase that typically functions
either as a toxin or as an immunity effector [68], appears to
alternately act in each of these capacities in the case of Cas13a
(Fig. 3). The mechanism of the trans-
formation of Cas13a from an immune
to a PCD/dormancy effector remains
to be elucidated. A conformational
change triggered by the formation of a
complex with the cognate target RNA
is a plausible, general explanation but
the specifics that should become clear
once structures of Cas13a complexed
with different substrates are solved are
of major interest. Regardless, however,
type VI-A systems are a showcase for
immunity-PCD coupling where the
immune machinery itself appears to
switch into suicidal mode.
Recently, two additional subtypes
of type VI CRISPR-Cas systems have
been discovered by computational
screening of bacterial genomes [84].
The effector proteins of all type VI
systems contain two HEPN domain,
and by analogy to subtype VI-A, can be
predicted to be able to switch to the
PCD/dormancy mode. Moreover, the
HEPN-containing proteins of Class 1
CRISPR-Cas systems might function in
a similar fashion, especially given that
some of these proteins combine a
HEPN domain with a CARF (CRISPR-
Associated Rossmann Fold) domain, a
potential stress sensor [69]. Although
the CARF domain-containing proteins
have not been studied biochemically,
several structures have been solved,
and the presence of a conserved
Rossmann fold strongly suggests that
these proteins bind ligands, most
likely nucleotide derivatives, and ac-
cordingly, could function as allosteric
regulators of other Cas proteins [69].
What governs
life-or-death decisions,
and why bother with
dedicated suicide
machinery?
Regardless of whether the cell that
turns on the self-afflicting program
kills itself right away or goes into
dormancy, with a chance of come-
back, the factors that determine the
decision are the same: the cell must
“predict” the outcome of infection and act accordingly
(Fig. 4). If, after the immune system recognizes foreign
invasion, the sensor module “predicts” that the onslaught is
likely to be manageable, the immune system is mobilized to
its full capacity. If, on the contrary, the forecast is dire, the
Figure 3. Type VI CRISPR-Cas systems: merging immunity with PCD. Upon infection with a
RNA phage, for which a cognate spacer(s) is available, the Cas13a-crRNA complex recognizes
and inactivates the target. However, the defense against DNA viruses is thought to proceed via
the PCD route whereby recognition of the target (a virus transcript) triggers a conformation
change in Cas13b, turning it into a promiscuous RNase. This activity then causes dormancy or
PCD, hence preventing virus reproduction. Modified with permission from [83].
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self-destruction program is turned on. The signals read by
the sensor are likely to differ between defense systems. In
some cases, the damage to the cell (genotoxic stress level)
could be measured directly as exemplified by the DSB
sensing by RloC [80]. The same ACNase as well as PrrC also
senses the increased concentration of dTTP which accu-
mulates during phage infection and effectively serves as an
alarmone [76, 86]. The ligand(s) that serves as the signal for
the CARF domain in the case of CRISPR-Cas system
remain to be identified but the possibility that the CARF
domain [69] is a toggle between the immune and self-
afflicting responses appears imminently plausible. The
nature of the switching signals, their threshold values and
what determines these, and whether these features
specifically depend on the character of virus-host interac-
tion, are all intriguing directions for further study.
Type VI-A CRISPR-Cas systems (and conceivably, other
variants of type VI) are a special case because they appear to
short-circuit the typical defense relay by skipping or at least
simplifying the damage-sensing step and employing the main
immune effector as the suicide effector as well (Figs. 3 and 4).
Indeed, Cas13a switches to the promiscuous mode in vitro
where the only signal comes from the recognition of the
target [83]. Type VI systems are rare among bacteria [84], and
this might reflect the high cost of these systems to the host due
to their “panic” response to invading DNA. Nevertheless,
sensing of the target RNA concentration, which would reflect
multiplicity of infection and/or the intensity of the expression
of the virus genome, by the Cas13 proteins themselves, could
occur even in this case. The more complex defense strategies
that involve the dedicated “forecast module” (sensor) (Fig. 4),
such as Class 1 CRISPR-Cas, are likely to outcompete the
simple ones where the self destruction program
is activated at the first alarm signal.
Both immune systems with their suicidal
proclivities, and especially, dedicated suicide
devicesareprone tomisfiringandare thus,costly
for the organism.What, then, are the factors that
underlie the broad (although not universal)
persistence of both these types of costly defense
strategies? Mathematical modeling of the coevo-
lution of different types of defense with patho-
gens as well as biological features of the defense
systems seem to offer some clues [87, 88].
Detailed analysis of the coevolution models
indicates that, assuming some basal level of
innate immunity, adaptive immunity, and sui-
cidecancoexistwithinarelativelysmall regionof
the parameter space where the efficacies of both
types of defense are limited [89]. Sucha situation
seems to correspond to the sensing toggle circuit
outlinedinFig.4,wherethesensor“predicts” the
outcome of infection and whether the immune
system is likely to cope successfully. These
considerations on coevolution of the immune
and suicidal defense strategies apply to both
adaptive immunity – which dominates when a
cell encounters a familiar virus or plasmid – and
innate immunitywhich acts against newcomers.
Immunity-suicide coupling is favored when
the system includes dual function components that are
involved both in immune and in suicidal activities [89]. This
could be the case for the Cas proteins, such as Cas2, which is
essential for adaptive immunity, but given its homology with
interferases, might also display toxic properties. Furthermore,
although the biological functions of the HEPN-containing
Cas proteins, such as Csm6 and Csx1, are not well understood,
it appears likely that they also contribute both to the
interference stage of the adaptive immune response and, as
toxins, to the self-destruction program [26, 68, 70, 90]. An
intriguing question that remains to be addressed experimen-
tally is whether or not CRISPR-Cas systems are capable of post-
segregational cell killing.
From a complementary perspective, the persistence of the
dedicated suicide systems as well as at least some immune
systems, such as RM, has to do with the fact that TA and RM
modules possess features of selfish genetic elements, or more
specifically, make the host cells addicted to these modules by
killing cells that purge them [91, 92].
Conclusions
Most organisms, even bacteria and archaea with small
genomes, possess multiple layers of anti-parasite defense
including both immune mechanisms that affect the invading
agents and suicidal mechanisms. The coexistence of these
fundamentally different defense strategies seems to be caused
by the limited efficacy of immune systems that can be
overcome by rapidly replicating parasites, under high
multiplicity of infection and in other situations. The immune
and suicidal strategies not only coexist and are often encoded
Figure 4. Switching from immunity to PCD through a sensor module. The sensors
can be different for different immune and PCD systems, and could sense DNA
damage directly, as in the case of RloC, or via an alarmone, possibly, a modified
nucleotide, that remains to be identified, as in the case of the CARF domains
associated with many CRISPR-Cas systems.
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in the same genomic loci but seem to be functionally coupled,
in particular by virtue of sharing protein components. There
are indications, although not yet solid evidence, that the
switch from the immune mode to the suicidal mode of defense
is governed by dedicated sensors that determine the level of
damage inflicted on the cell and on that basis “predict” the
outcome of the infection. In some cases, sensing the damage
can be short-circuited as exemplified by the subtype VI-A
CRISPR-Cas systems. However, such streamlined immunity-
suicide systems are rare, hence suggesting that foregoing
damage sensing could be costly. Although not the subject of
this article, coupling of immunity with PCD and elaborate
control of cell death are manifest also in eukaryotes and
appear to be important in host-parasite interactions [93].
Thus, linkage between immunity and PCD, or in other terms,
between parasite killing and suicide, appears to be a general
attribute of cellular life forms. Understanding the coupling
mechanisms as well as the specifics of damage sensing, which
allows the cells to forecast the outcome of the infection and
make informed life or death decisions, is an important and
exciting direction of further research.
The authors have declared no conflict of interest.
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